Cureline Acquired by ABS Bio — Healthcare M&A

ABS Bio has completed the acquisition of Cureline, a diagnostics imaging business in California, for $376 million. ABS Bio acquisitions aim to expand access to biospecimens and streamline end-to-end workflows supporting imaging and diagnostic testing. Cureline provides biospecimen-related services that enable healthcare providers and labs to execute diagnostics imaging programs more efficiently across CA. The add on acquisition is an announced strategic acquisition by ABS Bio, classified as a healthcare M&A deal in healthcare deals CA and CA acquisitions.